Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6.33K | $53.6K | $8.46 | Mar 28, 2025 | Direct |
Avalo Therapeutics, Inc. | Director | Common Stock | 3.17K | $26.8K | $8.46 | Mar 28, 2025 | Direct |
Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.6K | Aug 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVTX | Avalo Therapeutics, Inc. | Mar 28, 2025 | 2 | $0 | 4 | Apr 1, 2025 | Director |
AVTX | Avalo Therapeutics, Inc. | Aug 13, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Director |
AVTX | Avalo Therapeutics, Inc. | Mar 28, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Director |